InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers

Journal of the National Cancer Institute

Volumn 104, Issue 2, 2012, Pages 147-158

  Sitas, Freddy ^a   Egger, Sam ^a   Urban, Margaret I ^e,f   Taylor, Philip R ^c,d   Abnet, Christian C ^c,d   Boffetta, Paolo ^g   O'Connell, Dianne L ^a   Whiteman, David C ^h   Brennan, Paul ⁱ   Malekzadeh, Reza ^j   Pawlita, Michael ^b   Dawsey, Sanford M ^c,d   Waterboer, Tim ^b   Webb, Penelope M ^k   Green, Adèle C ^k   Hayward, Nicholas K ^k   Zaridze, David ^k   Holcatova, Ivana ^k   Mates, Dana ^k   Szeszenia Dabrowska, Neonila ^k   Ferro, Gilles ^k   Janout, Vladimir ^k   Curado, Maria Paula ^k   Menezes, Ana Maria ^k   Koifman, Sergio ^k   Islami, Farhad ^k   Nasrollahzadeh, Dariush ^k   Hu, Nan ^k   Goldstein, Alisa M ^k   Gao, Ying ^k   Ding, Ti ^k   Kamangar, Farin ^k   more..

^a CANCER RESEARCH DIVISION   (Australia)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN L1; PROTEIN ANTIBODY; PROTEIN E6; PROTEIN E7;

ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 4; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SMOKING; WART VIRUS;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS;

EID: 84862962583     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr499     Document Type: Article

References (62)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from http://globocan.iarc.fr. Accessed March 15, 2011.
2. International Agency for Research on Cancer Working Group. Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC; 2004.
3. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424-1433. (Pubitemid 47234314)
4. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007;8(4):292-293.
5. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005;113(3):456-463. (Pubitemid 40038715)
6. Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and esophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol. 2009;38(4):978-988.
7. Blot WF, McLaughlin JK. Chapter 8, Cancer of the Esophagus in Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006.
8. Mark SD, Qiao YL, Dawsey SM, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000;92(21):1753-1763.
9. Sewram V, De Stefani E, Brennan P, Boffetta P. Mate consumption and the risk of squamous cell esophageal cancer in Uruguay. Cancer Epidemiol Biomarkers Prev. 2003;12(6):508-513. (Pubitemid 36713644)
10. Islami F, Pourshams A, Nasrollahzadeh D, et al. Tea drinking habits and esophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ. 2009;338:b929.
11. Sammon AM. A case-control study of diet and social factors in cancer of the esophagus in Transkei. Cancer. 1992;69(4):860-865.
12. Ghadirian P, Vobecky J, Vobecky JS. Factors associated with cancer of the esophagus: an overview. Cancer Detect Prev. 1988;11(3-6):225-234.
13. Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to esophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer. 2008;98(11):1857-1863. (Pubitemid 351748837)
14. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527. (Pubitemid 36159887)
15. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19. (Pubitemid 29406813)
16. Naucler P, Chen HC, Persson K, et al. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study. J Gen Virol. 2007;88(pt 3):814-822. (Pubitemid 46359550)
17. Meschede W, Zumbach K, Braspenning J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol. 1998;36(2):475-480. (Pubitemid 28060316)
18. Heideman DA, Waterboer T, Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007;25(29):4550-4556. (Pubitemid 350035311)
19. Sitas F, Urban M, Stein L, et al. The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, esophagus and prostate in a black South African population. Infect Agent Cancer. 2007;2(6).
20. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-1783. (Pubitemid 38008900)
21. Zumbach K, Hoffmann M, Kahn T, et al. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer. 2000;85(6):815-818. (Pubitemid 30131472)
22. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-1956. (Pubitemid 46740304)
23. Syrjänen K, Pyrhönen S, Aukee S, et al. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol. 1982;5(4):291-296. (Pubitemid 13061962)
24. Syrjänen KJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch. 1982;52(4):283-292. (Pubitemid 12043121)
25. IARC Monographs Working Group. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: International Agency for Research on Cancer. Volume 100 Part B: Biological Agents. Lyon, France: IARC; 2011.
26. Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol. 2002;55(10):721-728. (Pubitemid 35231898)
27. Gillison ML, Shah KV. Chapter 9: the role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003;(31):57-65.
28. Campo MS. Papillomas and cancer in cattle. Cancer Surv. 1987;6(1):39-54.
29. Shen Z, Cen S, Shen J, et al. Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J Cancer Res Clin Oncol. 2000;126(10):589-594.
30. Dillner J. The serological response to papillomaviruses. Semin Cancer Biol. 1999;9(6):423-430. (Pubitemid 30184512)
31. Dillner J, Knekt P, Schiller JT, Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ. 1995;311(7016):1346.
32. Kamangar F, Qiao YL, Schiller JT, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer. 2006;119(3):579-584. (Pubitemid 43955711)
33. Bjørge T, Hakulinen T, Engeland A, et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 1997;57(18):3989-3992. (Pubitemid 27427687)
34. Lagergren J, Wang Z, Bergstrom R, Dillner J, Nyren O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst. 1999;91(2):156-162. (Pubitemid 29042693)
35. Van Doornum GJ, Korse CM, Buning-Kager JC, et al. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer. 2003;88(7):1095-1100. (Pubitemid 36560782)
36. Han C, Qiao G, Hubbert NL, et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst. 1996;88(20):1467-1471. (Pubitemid 26340048)
37. Michael KM, Waterboer T, Sehr P, et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog. 2008;4(6):e1000091.
38. Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005;51(10):1845-1853. (Pubitemid 41368175)
39. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 2006;309(1-2):200-204. (Pubitemid 43190816)
40. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the esophagus. Gut. 2008;57(2):173-180. (Pubitemid 351158042)
41. Sapkota A, Hsu CC, Zaridze D, et al. Dietary risk factors for squamous cell carcinoma of the upper aerodigestive tract in central and eastern Europe. Cancer Causes Control. 2008;19(10):1161-1170.
42. Szymanska K, Matos E, Hung RJ, et al. Drinking of maté and the risk of cancers of the upper aerodigestive tract in Latin America: a case-control study. Cancer Causes Control. 2010;21(11):1799-1806.
43. Gao Y, Hu N, Han X, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer. 2009;9(269).
44. Mqoqi N, Kellett P, Sitas F, Jula M. Incidence of Histologically Diagnosed Cancer in South Africa, 1998-1999. National Cancer Registry of South Africa. Johannesburg, South Africa: National Health Laboratory Service; 2004.
45. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality Books. 2006. http://www.aihw.gov.au/cancer/data/acim-books/index. cfm. Accessed November 15, 2010.
46. Semnani S, Sadjadi A, Fahimi S, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006;30(1):14-19. (Pubitemid 43374498)
47. Li J, Liu B, Li G, Rong S, Cao D, eds. Atlas of Cancer Mortality in the People's Republic of China. 1st ed. Shanghai, China: China Map Press; 1979.
48. Sehr P, Muller M, Hopfl R, et al. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods. 2002;106(1):61-70. (Pubitemid 35279650)
49. Kjaerheim K, Roe OD, Waterboer T, et al. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer. 2007;120(11):2459-2465. (Pubitemid 46642135)
50. Clifford GM, Shin HR, Oh JK, et al. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1874-1879. (Pubitemid 47450520)
51. Lee CH, Lee JM, Wu DC, et al. Carcinogenetic impact of ADH1B and ALDH2 genes on squamous cell carcinoma risk of the esophagus with regard to the consumption of alcohol, tobacco and betel quid. Int J Cancer. 2008;122(6):1347-1356.
52. Antonsson A, Nancarrow DJ, Brown IS, et al. High-risk human papillomavirus in esophageal squamous cell carcinoma. Australian Cancer Study. Cancer Epidemiol Biomarkers Prev. 2010;19(8):2080-2087.
53. Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med. 2001;20(14):2115-2130. (Pubitemid 32684633)
54. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560. (Pubitemid 37088507)
55. Franceschi S, Bidoli E, Negri E, Barbone F, La Vecchia C. Alcohol and cancers of the upper aerodigestive tract in men and women. Cancer Epidemiol Biomarkers Prev. 1994;3(4):299-304. (Pubitemid 24181573)
56. Lagergren J, Bergstrom R, Lindgren A, Nyren O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the esophagus and gastric cardia. Int J Cancer. 2000;85(3):340-346. (Pubitemid 30030406)
57. Mammas IN, Sourvinos G, Spandidos DA. Human papilloma virus (HPV) infection in children and adolescents. Eur J Pediatr. 2009;168(3):267-273.
58. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med. 2003;127(8):940-945. (Pubitemid 36994852)
59. Koshiol J, Wei WQ, Kreimer AR, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer. 2010;127(1):93-100.
60. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46. (Pubitemid 20255621)
61. Savitz DA, Olshan AF. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol. 1995;142(9):904-908.
62. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236-1238. (Pubitemid 28171344)